Paper33280239
Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
Li L and 9 others. J Cell Mol Med, 2021. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis. Papers, record 33280239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33280239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Activation | Major topic |
| Complement C5 | Major topic |
| Diabetic Nephropathies | Major topic |
| Gastrointestinal Tract | Major topic |
| Kidney | Major topic |
| STAT3 Transcription Factor | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Diabetes Mellitus, Experimental | |
| Endothelial Cells | |
| Fatty Acids | |
| Gastrointestinal Microbiome | |
| Homeostasis | |
| Humans | |
| Inflammation | |
| Mice | |
| Models, Biological | |
| Oxidative Stress | |
| Receptor, Anaphylatoxin C5a | |
| Transcriptome |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81700634 | National Natural Science Foundation of China | PubMed | ||
| 82070711 | National Natural Science Foundation of China | PubMed | ||
| Z20192002 | National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University. | PubMed | ||
| 2019YFS0279 | Key Research and Development (R&D) Project funded by Science and Technology Department of Sichuan Province | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21752957 | Transcriptome analysis of human diabetic kidney disease. | Diabetes | 2011 | https://conductscience.org/library/papers/21752957 | PubMed |
| 2 | 31510052 | High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31510052 | PubMed |
| 3 | 25589612 | Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. | J Am Soc Nephrol | 2015 | https://conductscience.org/library/papers/25589612 | PubMed |
| 4 | 31925859 | Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease. | Cell Prolif | 2020 | https://conductscience.org/library/papers/31925859 | PubMed |
| 5 | 24833634 | Microbiota and diabetes: an evolving relationship. | Gut | 2014 | https://conductscience.org/library/papers/24833634 | PubMed |
| 6 | 22674334 | Interactions between the microbiota and the immune system. | Science | 2012 | https://conductscience.org/library/papers/22674334 | PubMed |
| 7 | 25003516 | Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. | Gut Microbes | 2014 | https://conductscience.org/library/papers/25003516 | PubMed |
| 8 | 20664075 | Gut microbiota in health and disease. | Physiol Rev | 2010 | https://conductscience.org/library/papers/20664075 | PubMed |
| 9 | 24375052 | The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? | Nat Rev Nephrol | 2014 | https://conductscience.org/library/papers/24375052 | PubMed |
| 10 | 21808634 | Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. | Front Microbiol | 2011 | https://conductscience.org/library/papers/21808634 | PubMed |
| 11 | 12472776 | A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. | Kidney Int | 2003 | https://conductscience.org/library/papers/12472776 | PubMed |
| 12 | 16384831 | Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. | Nephrol Dial Transplant | 2006 | https://conductscience.org/library/papers/16384831 | PubMed |
| 13 | 18043660 | Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. | ISME J | 2007 | https://conductscience.org/library/papers/18043660 | PubMed |
| 14 | 31851794 | Glomerular podocytes in diabetic renal disease. | Adv Clin Exp Med | 2019 | https://conductscience.org/library/papers/31851794 | PubMed |
| 15 | 24143873 | Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants. | Scand J Infect Dis | 2013 | https://conductscience.org/library/papers/24143873 | PubMed |
| 16 | 33280239 | Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/33280239 | PubMed |
| 17 | 24080802 | The role of the glomerular endothelium in albumin handling. | Nat Rev Nephrol | 2013 | https://conductscience.org/library/papers/24080802 | PubMed |
| 18 | 21693741 | Temporal trends in the prevalence of diabetic kidney disease in the United States. | JAMA | 2011 | https://conductscience.org/library/papers/21693741 | PubMed |
| 19 | 22554833 | VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? | Metabolism | 2012 | https://conductscience.org/library/papers/22554833 | PubMed |
| 20 | 32576600 | Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin. | J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/32576600 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939591 | Complement-Metabolic Inflammation Crosstalk: Molecular Mechanisms and Therapeutic Targets in Type 2 Diabetes and Its Complications. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939591 | PubMed |
| 42076830 | Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression. | J Diabetes Res | 2026 | https://conductscience.org/library/papers/42076830 | PubMed |
| 41916963 | Complement 5a receptor 2 attenuates diabetic kidney disease by promoting mitochondria-associated endoplasmic reticulum membrane formation mediated by PSS-MFN2 interaction. | Cell Discov | 2026 | https://conductscience.org/library/papers/41916963 | PubMed |
| 41835120 | Gut Microbiota Dysbiosis and Metabolite Imbalance Mediate Diabetic Kidney Disease Inflammation: Mechanisms and Intervention Strategies Targeting Gut-Kidney Axis and NF-κB/NLRP3 Pathways. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41835120 | PubMed |
| 41657872 | The Role of Complement Component C5a in the Pathogenesis of Diabetic Kidney Disease: A New Kid on the Block? | Cureus | 2026 | https://conductscience.org/library/papers/41657872 | PubMed |
| 41440851 | SGLT2 Inhibitors Confer Cardiovascular Protection via the Gut-Kidney-Heart Axis: Mechanisms and Translational Perspectives. | J Cardiovasc Dev Dis | 2025 | https://conductscience.org/library/papers/41440851 | PubMed |
| 41189475 | Post-ischemia and reperfusion kidney injury is mitigated in a novel complement 5 knockout rat. | Physiol Rep | 2025 | https://conductscience.org/library/papers/41189475 | PubMed |
| 41096893 | A Targeted Blockade of Terminal C5a Is Critical to Management of Sepsis and Acute Respiratory Distress Syndrome: The Mechanism of Action of Vilobelimab. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096893 | PubMed |
| 40970493 | Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease. | Ann Med | 2025 | https://conductscience.org/library/papers/40970493 | PubMed |
| 40944292 | Gut Microbiome-Derived Short-Chain Fatty Acids in Glomerular Protection and Modulation of Chronic Kidney Disease Progression. | Nutrients | 2025 | https://conductscience.org/library/papers/40944292 | PubMed |
| 40840920 | Mechanism of Rhizoma Chuanxiong for the treatment of diabetic kidney disease based on network pharmacology. | Ren Fail | 2025 | https://conductscience.org/library/papers/40840920 | PubMed |
| 40830297 | Causal Relationship Between Serum Zinc Levels and Diabetic Kidney Disease (DKD): A Plasma Proteomics Mediation Study. | Biol Trace Elem Res | 2026 | https://conductscience.org/library/papers/40830297 | PubMed |
| 40775226 | Urinary Complement proteome strongly linked to diabetic kidney disease progression. | Nat Commun | 2025 | https://conductscience.org/library/papers/40775226 | PubMed |
| 40657042 | Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40657042 | PubMed |
| 40638782 | The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO study. | Am J Health Syst Pharm | 2026 | https://conductscience.org/library/papers/40638782 | PubMed |
| 40352935 | Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40352935 | PubMed |
| 40072066 | Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy. | Cells | 2025 | https://conductscience.org/library/papers/40072066 | PubMed |
| 39753879 | Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies. | Sci Rep | 2025 | https://conductscience.org/library/papers/39753879 | PubMed |
| 39636415 | Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/39636415 | PubMed |
| 39549180 | Discussion on the treatment of diabetic kidney disease based on the "gut-fat-kidney" axis. | Int Urol Nephrol | 2025 | https://conductscience.org/library/papers/39549180 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C5 | 727 | PubTator's text mining | https://conductscience.org/library/genes/727 | NCBI Gene |
| C5AR1 | 728 | PubTator's text mining | https://conductscience.org/library/genes/728 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33280239
GET https://conductscience.org/api/papers/v1/33280239/references?page=2